Anandamide And Delta 9-THC Dilation Of Cerebral Arterioles Is Blocked By Indomethacin

[Julie Gardener]

Anandamide And Delta 9-THC Dilation Of Cerebral Arterioles Is Blocked By Indomethacin​

E. F. Ellis, S. F. Moore, and K. A. Willoughby
+ Author Affiliations
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0613, USA.

AJP - Heart December 1995 vol. 269 no. 6 H1859-H1864

Abstract

Anandamide (AN, arachidonyl ethanolamide) has been isolated from the brain and shown to be an endogenous ligand for the delta 9-tetrahydrocannabinol (delta 9-THC) receptor. The purpose of these studies was to determine whether AN or delta 9-THC can affect the cerebral circulation. With the use of the closed cranial window AN and delta 9-THC (10(-13)-10(-3) M) were topically applied to rabbit cerebral arterioles and effects on diameter were measured with a microscope. AN and delta 9-THC similarly induced a dose-dependent dilation starting at concentrations as low as 10(-12) M. Maximum dilation for AN was 25% and that for delta 9-THC 22%. Topical coapplication of indomethacin, a cyclooxygenase inhibitor, completely blocked dilation, whereas the free radical scavengers superoxide dismutase and catalase or the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) had no effect on AN-induced dilation. The cerebrospinal fluid level of prostaglandin E2 increased only in response to 10(-7) M and greater AN and was not affected by delta 9-THC. [3H]AN superfused through the cranial window was 20% converted to arachidonic acid. These results show that AN and delta 9-THC can modulate cerebral arterioles, likely by stimulating release and metabolism of endogenous arachidonic acid. Whether dilation is due to vasodilator eicosanoids, or other vasoactive agents whose synthesis or release is cyclooxygenase dependent, is uncertain.

Copyright © 1995 the American Physiological Society

Articles citing this article
Roles of anandamide in the hepatic microcirculation in cirrhotic rats
Am. J. Physiol. Gastrointest. Liver Physiol. February 1, 2006 2902) G328-G334
AbstractFull TextFull Text (PDF)
U-46619 but not serotonin increases endocannabinoid content in middle cerebral artery: evidence for functional relevance
Am. J. Physiol. Heart Circ. Physiol. June 1, 2005 2886) H2694-H2701
AbstractFull TextFull Text (PDF)
Selective Ligands and Cellular Effectors of a G Protein-Coupled Endothelial Cannabinoid Receptor
Mol. Pharmacol. March 1, 2003 633) 699-705
AbstractFull TextFull Text (PDF)
Decrease in Efficacy and Potency of Nonsteroidal Anti-Inflammatory Drugs by Chronic Delta 9-Tetrahydrocannabinol Administration
J. Pharmacol. Exp. Ther. October 1, 2002 3031) 340-346
AbstractFull TextFull Text (PDF)
Regional Differences in Anandamide- and Methanandamide-Induced Membrane Potential Changes in Rat Mesenteric Arteries
J. Pharmacol. Exp. Ther. April 13, 2001 2962) 322-328
AbstractFull Text
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current
Am. J. Physiol. Heart Circ. Physiol. June 1, 1999 2766) H2085-H2093
AbstractFull TextFull Text (PDF)
A Role for N-Arachidonylethanolamine (Anandamide) as the Mediator of Sensory Nerve-Dependent Ca2+-Induced Relaxation
J. Pharmacol. Exp. Ther. April 1, 1999 2891) 245-250
AbstractFull Text
Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension
FASEB J. August 1, 1998 1211) 1035-1044
AbstractFull Text
Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels
Physiol. Rev. January 1, 1998 781) 53-97
AbstractFull TextFull Text (PDF)
The Biodisposition and Metabolism of Anandamide in Mice
J. Pharmacol. Exp. Ther. July 1, 1997 2821) 243-247
AbstractFull Text

Source: Anandamide and delta 9-THC dilation of cerebral arterioles is blocked by indomethacin